Go to the profile of BioPact

BioPact

 

About BioPact

BioPact’s innovative drug delivery platform, Medical Grade Molecular Rebar (MGMR™), comprises discrete, individualized, pure, length-controlled, surface-functionalized carbon nanotubes (CNT). By utilizing our patented technology, drug developers can solve challenges in many arenas such as: controlled release, targeted delivery, transdermal delivery, toxicity, physiological instability, intracellular delivery, or crossing the blood-brain barrier. The unique properties of these tubes overcome the limitations of traditional CNT which are impure, tangled bundles of carbon. MGMR can be internally loaded with large and/or small molecules, regardless of chemistries, while the exterior of the tube is available for functionalization with bioactive agents to create a targeted drug delivery system.

Therapeutic Areas

Oncology

Technologies

Drug delivery Nanotechnology

Company Type

Pharmaceutical

State of Ownership

Other

Influencer Of

Topics

Editions participated in:

November 2016